Status:
RECRUITING
Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
Colorado Clinical & Translational Sciences Institute
Conditions:
Cannabis Use
Eligibility:
All Genders
14-25 years
Phase:
NA
Brief Summary
This project seeks to learn more about the effects of cannabis use on the endocannabinoid system and endogenous opioid systems in adolescents to address a fundamental gap in knowledge and identify bio...
Detailed Description
Learning the effects of cannabis use on the endocannabinoid system and endogenous opioid systems in adolescents addresses a fundamental gap in knowledge and may identify biomarkers that help distingui...
Eligibility Criteria
Inclusion
- 14 to 25 years of age.
- Use cannabis at least twice a week for the past month.
Exclusion
- Refusal of valid written consent,
- Current psychosis,
- Obvious intoxication,
- Current risk of suicide,
- Violence sufficiently great to interfere with evaluation or to endanger evaluators,
- Obvious intellectual deficiency as noted during the informed consent process, or inability of patient or family to comply with the study protocol.
- Use of other illicit drugs in the past 90 days by self-report or detected by urine drug test.
- Use of opioid medications for medical or recreational purposes currently or within the past 90 days.
- Does not have access to an Internet connected devise or cannot use Zoom.
Key Trial Info
Start Date :
October 13 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05396638
Start Date
October 13 2022
End Date
December 1 2025
Last Update
February 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States, 80045